C4 Therapeutics Ownership | Who Owns C4 Therapeutics?
C4 Therapeutics Ownership Summary
C4 Therapeutics is owned by 5.77% institutional investors, 7.19% insiders, and 87.04% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 10.00% of CCCC shares. Wasatch Ultra Growth is the top mutual fund, with 7.25% of its assets in C4 Therapeutics shares.
CCCC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | C4 Therapeutics | 5.77% | 7.19% | 87.04% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Lynx1 capital management lp | 7.10M | 10.00% | $15.76M |
| Soleus capital management | 7.05M | 9.93% | $15.66M |
| Orbimed advisors | 5.24M | 7.37% | $11.62M |
| Morgan stanley | 4.97M | 7.00% | $11.04M |
| Wasatch advisors lp | 4.85M | 6.83% | $10.77M |
| Blackrock | 4.55M | 6.61% | $21.03M |
| Vanguard group | 3.19M | 4.49% | $7.09M |
| Silverarc capital management | 1.90M | 2.67% | $4.21M |
| Bank of america corp /de/ | 1.77M | 2.57% | $8.17M |
| Blackrock funding, inc. /de | 1.60M | 2.25% | $3.54M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lynx1 capital management lp | 7.10M | 3.21% | $15.76M |
| Soleus capital management | 7.05M | 0.79% | $15.66M |
| Silverarc capital management | 1.90M | 0.57% | $4.21M |
| Orbimed advisors | 5.24M | 0.27% | $11.62M |
| Bain capital life sciences investors | 1.11M | 0.16% | $2.47M |
| Intrepid family office | 70.00K | 0.13% | $155.40K |
| Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group | 85.00K | 0.11% | $188.70K |
| Shay capital | 420.00K | 0.08% | $932.40K |
| Tang capital management | 900.00K | 0.08% | $2.00M |
| Wasatch advisors lp | 4.85M | 0.06% | $10.77M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.55M | 0.00% | 3.65M |
| Silverarc capital management | 1.90M | 0.57% | 1.90M |
| Shay capital | 420.00K | 0.08% | 420.00K |
| Morgan stanley | 4.97M | 0.00% | 217.84K |
| Vanguard group | 3.19M | 0.00% | 173.53K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -4.88M |
| Commodore capital lp | - | - | -3.41M |
| Samlyn capital | - | - | -3.02M |
| Wasatch advisors lp | 4.85M | 0.06% | -2.57M |
| Orbimed advisors | 5.24M | 0.27% | -1.60M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Qube research | 115.97K | 0.00% | 115.97K | $257.46K |
| Algert global | 106.30K | 0.00% | 106.30K | $236.00K |
| Marshall wace, llp | 106.28K | 0.00% | 106.28K | $235.93K |
| State of wyoming | 82.51K | 0.02% | 82.51K | $183.17K |
| Graham capital management | 40.63K | 0.00% | 40.63K | $90.19K |
Sold Out
| Holder | Change |
|---|---|
| Gradient investments | -25.00 |
| True wealth design | -31.00 |
| Coldstream capital management | -52.00 |
| Capital performance advisors llp | -54.00 |
| Rothschild investment | -70.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 21 | -78.79% | 4,095,962 | -91.57% | 5 | 0.12% | 9 | -83.33% | 9 | -72.73% |
| Jun 30, 2025 | 100 | -13.04% | 54,689,267 | -14.68% | 77 | 0.90% | 55 | -19.12% | 33 | 17.86% |
| Mar 31, 2025 | 6 | -95.20% | 21,025,800 | -67.35% | 30 | 0.35% | 4 | -93.85% | 1 | -96.97% |
| Dec 31, 2024 | 122 | -5.43% | 64,367,933 | 0.29% | 92 | 1.09% | 63 | -7.35% | 33 | 3.13% |
| Sep 30, 2024 | 126 | 5.88% | 64,029,825 | 5.20% | 91 | 1.18% | 67 | 1.52% | 33 | -2.94% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Wasatch Ultra Growth | 5.15M | 7.25% | 593.72K |
| Vanguard US Total Market Shares ETF | 2.14M | 3.01% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.03M | 2.85% | -44.74K |
| Biotech Growth Ord | 1.75M | 2.46% | - |
| SPDR® S&P Biotech ETF | 1.57M | 2.22% | 22.34K |
| iShares Russell 2000 ETF | 1.53M | 2.16% | - |
| Wasatch Micro Cap | 758.27K | 1.07% | -483.88K |
| Fidelity Small Cap Index | 623.59K | 0.88% | -8.75K |
| Vanguard Institutional Extnd Mkt Idx Tr | 608.71K | 0.86% | -231.45K |
| iShares Russell 2000 Value ETF | 560.98K | 0.79% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2025 | Boyle Scott N | Chief Business Officer | Sell | $2.11K |
| Feb 14, 2025 | Boyle Scott N | Chief Business Officer | Sell | $1.54K |
| Feb 08, 2023 | Koppikar Utpal | - | Buy | $31.74K |
| Apr 12, 2022 | Hirsch Andrew | President & CEO | Buy | $84.00K |
| Jan 04, 2022 | Crystal Adam | Chief Medical Officer | Sell | $440.55K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 2 |
| 2024 Q4 | - | - |
CCCC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools